Assembly Biosciences Reports Second Quarter 2025 Financial Results and Recent Updates
Assembly Biosciences Reports Second Quarter 2025 Financial Results and Recent Updates GlobeNewswire August 06, 2025 – On track for proof-of-concept Phase 1b data no later than this fall in participants with recurrent genital herpes for long-acting herpes simplex virus (HSV) helicase-primase inhibitor candidates, ABI-5366 and ABI-1179 – – Positive topline data reported for Phase 1b […]